Document:

EXHIBIT 10.1

                          HEALTHCARE TECHNOLOGIES LTD.

                                    THE 2003
                          ISRAELI SHARE AND OPTION PLAN
                        AS AMENDED AS OF AUGUST 27, 2007

                                       1
<PAGE>

                                TABLE OF CONTENTS

1. PURPOSE OF THE ISOP                                                         3

2. DEFINITIONS                                                                 3

3. ADMINISTRATION OF THE ISOP                                                  6

4. DESIGNATION OF PARTICIPANTS                                                 7

5. DESIGNATION OF AWARDS PURSUANT TO SECTION 102                               8

6. TRUSTEE                                                                     9

7. SHARES RESERVED FOR THE ISOP                                               10

8. PURCHASE PRICE                                                             10

9. ADJUSTMENTS                                                                10

10. TERM AND EXERCISE OF OPTIONS                                              12

11. TERM OF THE SHARES                                                        13

12. VESTING OF AWARDS                                                         14

13. SHARES SUBJECT TO RIGHT OF FIRST REFUSAL                                  15

14. DIVIDENDS                                                                 15

15. RESTRICTIONS ON ASSIGNABILITY AND SALE OF AWARDS                          15

16. EFFECTIVE DATE AND DURATION OF THE ISOP                                   16

17. AMENDMENTS OR TERMINATION                                                 16

18. GOVERNMENT REGULATIONS                                                    16

19. CONTINUANCE OF EMPLOYMENT                                                 16

20. GOVERNING LAW & JURISDICTION                                              16

21. TAX CONSEQUENCES                                                          17

22. NON-EXCLUSIVITY OF THE ISOP                                               17

23. MULTIPLE AGREEMENTS                                                       17

                                       2
<PAGE>

     This plan, as amended from time to time, shall be known as Healthcare
     Technologies Ltd. 2003 Israeli Share and Option Plan, as amended as of
     August 27, 2007 (the "ISOP").

1.   PURPOSE OF THE ISOP

     The ISOP is intended to provide an incentive to retain, in the employ of
     Healthcare Technologies Ltd. (the "COMPANY") and its Affiliates (as defined
     below), persons of training, experience, and ability, to attract new
     employees, directors or consultants whose services are considered valuable
     to the Company, to encourage the sense of proprietorship of such persons,
     and to stimulate the active interest of such persons in the development and
     financial success of the Company by providing them with opportunities to
     purchase Shares in the Company, pursuant to the ISOP.

2.   DEFINITIONS

     For purposes of the ISOP and related documents, including the Award
     Agreement, the following definitions shall apply:

     2.1  "AFFILIATE" means any "employing company" within the meaning of
          Section 102(a) of the Ordinance.

     2.2  "APPROVED 102 AWARD" means an Award granted pursuant to Section 102(b)
          of the Ordinance and held in trust by a Trustee for the benefit of the
          Grantee.

     2.3  "AWARD" means an Option and/or Restricted Share granted to a Grantee,
          as the case may be, under the ISOP.

     2.4  "102 AWARD" means any Award granted to Employees pursuant to Section
          102 of the Ordinance.

     2.5  "AWARD AGREEMENT" means the share agreement or the option agreement
          between the Company and a Grantee that sets out the terms and
          conditions of a Restricted Share or an Option allocated or issued to
          the Grantee.

     2.6  "BOARD" means the Board of Directors of the Company.

     2.7  "CAPITAL GAIN AWARD (CGA)" as defined in Section 5.4 below.

                                       3
<PAGE>

     2.8  "CAUSE" means, (i) conviction of any felony involving moral turpitude
          or affecting the Company; (ii) any refusal to carry out a reasonable
          directive of the chief executive officer, the Board or the Grantee's
          direct supervisor, which involves the business of the Company or its
          Affiliates and was capable of being lawfully performed; (iii)
          embezzlement of funds of the Company or its Affiliates; (iv) any
          breach of the Grantee's fiduciary duties or duties of care of the
          Company; including without limitation disclosure of confidential
          information of the Company; and (v) any conduct (other than conduct in
          good faith) reasonably determined by the Board to be materially
          detrimental to the Company.

     2.9  "CHAIRMAN" means the chairman of the Committee.

     2.10 "COMMITTEE" means a compensation committee appointed by the Board,
          which shall consist of no fewer than two members of the Board.

     2.11 "COMPANY" means Healthcare Technologies Ltd., an Israeli company.

     2.12 "COMPANIES LAW" means the Israeli Companies Law 5759-1999.

     2.13 "CONTROLLING SHAREHOLDER" shall have the meaning ascribed to it in
          Section 32(9) of the Ordinance.

     2.14 "DATE OF GRANT" means, the date of grant of an Option or a Restricted
          Share, as determined by the Board and set forth in the Grantee's Award
          Agreement.

     2.15 "EMPLOYEE" means a person who is employed by the Company or its
          Affiliates, including a non-employee individual who is serving as a
          director or an office holder, but excluding a Controlling Shareholder.

     2.16 "EXPIRATION DATE" means the date upon which an Option shall expire, as
          set forth in Section 10.3 of the ISOP.

     2.17 "FAIR MARKET VALUE" means as of any date, the value of a Share
          determined as follows:

          (i) If the Shares are listed on any established stock exchange or a
          national market system, including without limitation the NASDAQ Global
          Market system, or the NASDAQ Capital Market of the NASDAQ Stock
          Market, the Fair Market Value shall be the closing sales price for
          such Shares (or the closing bid, if no sales were reported), as quoted
          on such exchange or system for the last market trading day prior to
          time of determination, as reported in the Wall Street Journal, or such
          other source as the Board deems reliable. Without derogating from the
          above, solely for the purpose of determining the tax liability
          pursuant to Section 102(b)(3) of the Ordinance, if at the Date of
          Grant the Company's shares are listed on any established stock
          exchange or a national market system or if the Company's shares will
          be registered for trading within ninety (90) days following the Date
          of Grant, the Fair Market Value of a Share at the Date of Grant shall
          be determined in accordance with the average value of the Company's
          shares on the thirty (30) trading days preceding the Date of Grant or
          on the thirty (30) trading days following the date of registration for
          trading, as the case may be;

                                       4
<PAGE>

          (ii) If the Shares are regularly quoted by a recognized securities
          dealer but selling prices are not reported, the Fair Market Value
          shall be the mean between the high bid and low asked prices for the
          Shares on the last market trading day prior to the day of
          determination, or;

          (iii) In the absence of an established market for the Shares, the Fair
          Market Value thereof shall be determined in good faith by the Board.

     2.18 "GRANTEE" means a person who receives or holds an Award under the
          ISOP.

     2.19 "ISOP" means this 2003 Israeli Share and Option Plan as amended as of
          August 27, 2007.

     2.20 "ITA" means the Israeli Tax Authorities.

     2.21 "NON-EMPLOYEE" means a consultant, adviser, service provider,
          Controlling Shareholder or any other person who is not an Employee.

     2.21A "OPTION" means an option to purchase one or more Shares pursuant to
          the ISOP.

     2.22 "ORDINARY INCOME AWARD (OIA)" as defined in Section 5.5 below.

     2.23 "3(I) OPTION" means an Option granted pursuant to Section 3(i) of the
          Ordinance to any person who is Non- Employee.

     2.24 "ORDINANCE" means the Israeli Income Tax Ordinance [New Version] 1961
          as now in effect or as hereafter amended.

     2.25 "PURCHASE PRICE" means the price for each Share subject to an Award
          (as and if applicable).

     2.26 "RESTRICTED SHARES" means an Award of Shares under this ISOP that is
          subject to the terms and conditions of Section 11.

     2.27 "SECTION 102" means section 102 of the Ordinance as now in effect or
          as hereafter amended.

     2.28 "SHARE" means the ordinary shares, NIS 0.04 par value each, of the
          Company.

     2.29 "SUCCESSOR COMPANY" means any entity the Company is merged to or is
          acquired by, in which the Company is not the surviving entity.

     2.30 "TRANSACTION" means (i) merger, acquisition or reorganization of the
          Company with one or more other entities in which the Company is not
          the surviving entity, (ii) a sale of all or substantially all of the
          assets of the Company.

     2.31 "TRUSTEE" means any individual appointed by the Company to serve as a
          trustee and approved by the ITA, all in accordance with the provisions
          of Section 102(a) of the Ordinance.

                                       5
<PAGE>

     2.32 "UNAPPROVED 102 AWARD" means an Award granted pursuant to Section
          102(c) of the Ordinance and not held in trust by a Trustee.

     2.33 "VESTED AWARD" means any Award, which has already been vested
          according to the Vesting Dates.

     2.34 "VESTING DATES" means, as determined by the Board or by the Committee,
          the date as of which the Grantee shall be entitled to exercise the
          Awards or part of the Awards, as set forth in section 12 of the ISOP.

3.   ADMINISTRATION OF THE ISOP

     3.1  The Board shall have the power to administer the ISOP either directly
          or upon the recommendation of the Committee, all as provided by
          applicable law and in the Company's Articles of Association.
          Notwithstanding the above, the Board shall automatically have residual
          authority if no Committee shall be constituted or if such Committee
          shall cease to operate for any reason.

     3.2  The Committee shall select one of its members as its Chairman and
          shall hold its meetings at such times and places as the Chairman shall
          determine. The Committee shall keep records of its meetings and shall
          make such rules and regulations for the conduct of its business as it
          shall deem advisable.

          Any member of such Committee shall be eligible to receive Awards under
          the ISOP while serving on the Committee, unless otherwise specified
          herein.

     3.3  Subject to the general terms and conditions of the ISOP, and in
          particular the terms and conditions detailed below, the Committee
          shall have the power and authority to recommend to the Board and the
          Board shall have the full power and authority (i) to designate
          participants; (ii) to determine the terms and provisions of the
          respective Award Agreements (which need not be identical), including,
          but not limited to, the number of Shares in the Company to be covered
          by each Award, provisions concerning the time and the extent to which
          the Awards may be exercised and the nature and duration of
          restrictions as to the transferability or restrictions constituting
          substantial risk of forfeiture; (iii) to accelerate the right of an
          Optionee to exercise, in whole or in part, any previously granted
          Option; (iv) to interpret the provisions and supervise the
          administration of the ISOP; (v) to determine the Fair Market Value of
          the Shares; (vi) make an election as to the type of Approved 102
          Award; (vii) to designate the type of Options, and (iv) to determine
          any other matter which is necessary or desirable for, or incidental to
          administration of the ISOP. The Board may, in its sole discretion,
          delegate some or all of the powers listed above to the Committee, to
          the extent permitted by the Companies Law, its Articles of Association
          or other applicable law, rules and regulations.

                                       6
<PAGE>

     3.4  Notwithstanding the above, the Committee shall not be entitled to
          grant Options to the Grantees (unless permitted to do so by the
          Companies Law). However, in the event that the Committee is authorized
          to do so by the Board, it may issue Shares underlying Options which
          have been granted by the Board and duly exercised pursuant to the
          provisions hereof, in accordance with Sections 112(a)(5) and 288 of
          the Companies Law.

     3.5  The Board shall have the authority to grant, at its discretion, to the
          holder of an outstanding Award, in exchange for the surrender and
          cancellation of such Award, a new Award having a purchase price equal
          to, lower than or higher than the Purchase Price of the original Award
          so surrendered and canceled and containing such other terms and
          conditions as the Committee may prescribe in accordance with the
          provisions of the ISOP.

     3.6  Subject to the Company's Articles of Association, all decisions and
          selections made by the Board or the Committee pursuant to the
          provisions of the ISOP shall be made by a majority of its members
          except that no member of the Board or the Committee shall vote on, or
          be counted for quorum purposes, with respect to any proposed action of
          the Board or the Committee relating to any Award to be granted to that
          member. Any decision reduced to writing and signed by all of the
          members of the Board or Committee, as the case may be, shall be fully
          effective as if it had been at a meeting duly held.

     3.7  The interpretation and construction by the Committee of any provision
          of the ISOP or of any Award Agreement thereunder shall be final and
          conclusive unless otherwise determined by the Board. To avoid doubt,
          the Board may at any time exercise any powers, notwithstanding the
          fact that a Committee has been appointed.

     3.8  Subject to the Company's Articles of Association and the Company's
          decision, and to all approvals legally required, including, but not
          limited to the provisions of the Companies Law, each member of the
          Board or the Committee shall be indemnified and held harmless by the
          Company against any cost or expense (including counsel fees)
          reasonably incurred by him, or any liability (including any sum paid
          in settlement of a claim with the approval of the Company) arising out
          of any act or omission to act in connection with the ISOP unless
          arising out of such member's own fraud or bad faith, to the extent
          permitted by applicable law. Such indemnification shall be in addition
          to any rights of indemnification the member may have as a director or
          otherwise under the Company's Articles of Association, any agreement,
          any vote of shareholders or disinterested directors, insurance policy
          or otherwise.

     3.9  The Board and/or the Committee shall have the authority to adopt,
          alter and repeal such administrative rules, guidelines and practices
          governing the ISOP and perform all acts, including the delegation of
          its responsibilities (to the extent permitted by applicable law and
          applicable stock exchange rules), as it shall, from time to time, deem
          advisable; to construe and interpret the terms and provisions of the
          ISOP and any Award issued under the ISOP (and any agreements relating
          thereto); and to otherwise supervise the administration of the ISOP.
          The Board and/or Committee may correct any defect, supply any omission
          or reconcile any inconsistency in the ISOP or in any agreement
          relating thereto in the manner and to the extent it shall deem
          necessary to effectuate the purpose and intent of the ISOP.

                                       7
<PAGE>

4.   DESIGNATION OF PARTICIPANTS

     The persons eligible for participation in the ISOP as Grantees shall
     include any Employees and/or Non-Employees of the Company or of any
     Affiliate; provided, however, that: (i) Employees may only be granted 102
     Awards; (ii) Non-Employees may only be granted 3(i) Options; and (iii)
     Controlling Shareholders may only be granted 3(i) Options.

     The grant of an Award hereunder shall neither entitle the Grantee to
     participate nor disqualify the Grantee from participating in, any other
     grant of Awards pursuant to the ISOP or any other option and/or share plan
     of the Company or any of its Affiliates.

     Anything in the ISOP to the contrary notwithstanding, all grants of Awards
     to directors and office holders shall be authorized and implemented in
     accordance with the provisions of the Companies Law or any successor act or
     regulation, as in effect from time to time.

5.   DESIGNATION OF AWARDS PURSUANT TO SECTION 102

     5.1  The Company may designate Awards granted to Employees pursuant to
          Section 102 as Unapproved 102 Awards or Approved 102 Awards.

     5.2  The grant of Approved 102 Awards shall be made under this ISOP adopted
          by the Board, and shall be conditioned upon the approval of this ISOP
          by the ITA.

     5.3  Approved 102 Award may either be classified as Capital Gain Award
          ("CGA") or Ordinary Income Award ("OIA").

     5.4  Approved 102 Award elected and designated by the Company to qualify
          under the capital gain tax treatment in accordance with the provisions
          of Section 102(b)(2) shall be referred to herein as CGA.

     5.5  Approved 102 Award elected and designated by the Company to qualify
          under the ordinary income tax treatment in accordance with the
          provisions of Section 102(b)(1) shall be referred to herein as OIA.

     5.6  The Company's election of the type of Approved 102 Awards as CGA or
          OIA granted to Employees (the "ELECTION"), shall be appropriately
          filed with the ITA before the Date of Grant of an Approved 102 Award.
          Such Election shall become effective beginning the first Date of Grant
          of an Approved 102 Award under this ISOP and shall remain in effect
          until the end of the year following the year during which the Company
          first granted Approved 102 Awards. The Election shall obligate the
          Company to grant ONLY the type of Approved 102 Award it has elected,
          and shall apply to all Grantees who were granted Approved 102 Awards
          during the period indicated herein, all in accordance with the
          provisions of Section 102(g) of the Ordinance. For the avoidance of
          doubt, such Election shall not prevent the Company from granting
          Unapproved 102 Awards simultaneously.

     5.7  All Approved 102 Awards must be held in trust by a Trustee, as
          described in Section 6 below.

                                       8
<PAGE>

     5.8  For the avoidance of doubt, the designation of Unapproved 102 Awards
          and Approved 102 Awards shall be subject to the terms and conditions
          set forth in Section 102 of the Ordinance and the regulations
          promulgated thereunder.

     5.9  With regards to Approved 102 Awards, the provisions of the ISOP and/or
          the Award Agreement shall be subject to the provisions of Section 102
          and the Tax Assessing Officer's permit, and the said provisions and
          permit shall be deemed an integral part of the ISOP and of the Award
          Agreement. Any provision of Section 102 and/or the said permit which
          is necessary in order to receive and/or to keep any tax benefit
          pursuant to Section 102, which is not expressly specified in the ISOP
          or the Award Agreement, shall be considered binding upon the Company
          and the Grantees.

6.   TRUSTEE

     6.1  Approved 102 Awards which shall be granted under the ISOP and/or any
          Shares allocated or issued upon exercise or vesting, as the case may
          be, of such Approved 102 Awards and/or other shares received
          subsequently following any realization of rights, including without
          limitation bonus shares, shall be allocated or issued to the Trustee
          and held for the benefit of the Grantees for such period of time as
          required by Section 102 or any regulations, rules or orders or
          procedures promulgated thereunder (the "HOLDING PERIOD"). In the case
          the requirements for Approved 102 Awards are not met, then the
          Approved 102 Awards may be treated as Unapproved 102 Awards, all in
          accordance with the provisions of Section 102 and regulations
          promulgated thereunder.

     6.2  Notwithstanding anything to the contrary, the Trustee shall not
          release any Shares allocated or issued upon exercise or vesting, as
          the case may be, of Approved 102 Awards prior to the full payment of
          the Grantee's tax liabilities arising from Approved 102 Awards which
          were granted to him and/or any Shares allocated or issued upon
          exercise or vesting, as the case may be, of such Awards.

     6.3  With respect to any Approved 102 Award, subject to the provisions of
          Section 102 and any rules or regulation or orders or procedures
          promulgated thereunder, a Grantee shall not sell or release from trust
          any Share received upon the exercise or vesting, as the case may be,
          of an Approved 102 Award and/or any share received subsequently
          following any realization of rights, including without limitation,
          bonus shares, until the lapse of the Holding Period required under
          Section 102 of the Ordinance. Notwithstanding the above, if any such
          sale or release occurs during the Holding Period, the sanctions under
          Section 102 of the Ordinance and under any rules or regulation or
          orders or procedures promulgated thereunder shall apply to and shall
          be borne by such Grantee.

     6.4  Upon receipt of an Approved 102 Award, the Grantee will sign an
          undertaking to release the Trustee from any liability in respect of
          any action or decision duly taken and bona fide executed in relation
          with the ISOP, or any Approved 102 Award or Share granted to him
          thereunder.

                                       9
<PAGE>

7.   SHARES RESERVED FOR THE ISOP; RESTRICTION THEREON

     7.1  The Company has reserved 2,000,000 (two million) authorized but
          unissued Shares, for the purposes of the ISOP, subject to adjustment
          as set forth in Section 9 below. Any Shares which remain unissued and
          which are not subject to the outstanding Awards at the termination of
          the ISOP shall cease to be reserved for the purpose of the ISOP, but
          until termination of the ISOP the Company shall at all times reserve
          sufficient number of Shares to meet the requirements of the ISOP.
          Should any Award for any reason expire or be canceled prior to its
          exercise or relinquishment in full, the Shares subject to such Award
          may again be subjected to an Award under the ISOP or under the
          Company's other share and option plans.

     7.2  Each Award granted pursuant to the ISOP, shall be evidenced by a
          written Award Agreement between the Company and the Grantee, in such
          form as the Board or the Committee shall from time to time approve.
          Each Award Agreement shall state, inter-alia, the number of Shares to
          which the Award relates, the type of Award granted thereunder (whether
          a CGA, OIA, Unapproved 102 Award or a 3(i) Option).

8.   PURCHASE PRICE

     8.1  The Purchase Price of each Share subject to an Award shall be
          determined by the Committee in its sole and absolute discretion in
          accordance with applicable law, subject to any guidelines as may be
          determined by the Board from time to time and in no event less then
          the nominal value of the Share underlying the Award. Each Award
          Agreement will contain the Purchase Price determined for each Grantee.

     8.2  The Purchase Price shall be payable upon the exercise of the Award in
          a form satisfactory to the Committee, including without limitation, by
          cash or check. The Committee shall have the authority to postpone the
          date of payment on such terms as it may determine.

9.   ADJUSTMENTS

     Upon the occurrence of any of the following described events, Grantee's
     rights to purchase Shares under the ISOP shall be adjusted as hereafter
     provided:

     9.1  In the event of Transaction, the unexercised or restricted portion of
          each Award then outstanding under the ISOP shall be assumed or
          substituted to an appropriate number of Options or shares of the
          Successor Company (or a parent or subsidiary of the Successor Company)
          which were distributed to the shareholders of the Company in
          connection and with respect to such shares and appropriate adjustments
          shall be made in the Purchase Price per share to reflect such action,
          and all other terms and conditions of the Award Agreements, such as
          the vesting dates or terms of the Restricted Shares, shall remain in
          force, all as will be determined by the Committee, whose determination
          shall be final.

     9.2  Notwithstanding the above and subject to any applicable law, unless
          the Board or the Committee determines otherwise with respect to
          certain Award Agreements, there shall be a clause in each Award
          Agreement including that if in any such transaction described in
          section 9.1 above, the Successor Company (or parent or subsidiary of
          the Successor Company) does not agree to assume or substitute for the
          Options or Restricted Shares, the Vesting Dates shall be accelerated
          so that any unvested Option or Restricted Share or any portion thereof
          shall be immediately vested as of the date which is ten (10) days
          prior to the effective date of the Transaction.

                                       10
<PAGE>

     9.3  For the purposes of section 9.1 above, an Option or Restricted Share
          shall be considered assumed or substituted if, following the
          Transaction, the Option or Restricted Share confers the right to
          purchase or receive, for each Option or Restricted Share immediately
          prior to the Transaction, the consideration (whether shares, options,
          cash, or other securities or property) received in the Transaction by
          holders of Shares for each Share held on the effective date of the
          Transaction (and if such holders were offered a choice of
          consideration, the type of consideration chosen by the holders of a
          majority of the outstanding Shares); provided, however, that if such
          consideration received in the merger or acquisition is not solely
          ordinary shares (or their equivalent) of the Successor Company or its
          parent or subsidiary, the Committee may, with the consent of the
          Successor Company, provide for the consideration to be received upon
          the exercise or vesting of the Option or Restricted Share, as the case
          may be, to be solely ordinary shares (or their equivalent) of the
          Successor Company or its parent or subsidiary equal in Fair Market
          Value to the per Share consideration received by holders of a majority
          of the outstanding shares in the Transaction; and provided further
          that the Committee may determine, in its discretion and subject to the
          Board approval, that in lieu of such assumption or substitution of an
          Option or Restricted Share for options of the Successor Company or its
          parent or subsidiary, such Awards will be substituted for any other
          type of asset or property including cash which is fair under the
          circumstances.

     9.4  If the Company is voluntarily liquidated or dissolved while
          unexercised Options or unvested Restricted Shares remain outstanding
          under the ISOP, then the Board, in its own discretion, may determine
          that all such outstanding Options may be exercised in full by the
          Grantees and all Restricted Shares shall be vested as of the effective
          date of such liquidation or dissolution of the Company without regard
          to the vesting provisions of Paragraph 9(2) of the ISOP. If the Board
          determines that the outstanding Options may be exercised, all such
          outstanding Options may be exercised in full by the Grantees giving
          notice in writing to the Company of their intention to so exercise.

     9.5  If the outstanding shares of the Company shall at any time be changed
          or exchanged by declaration of a share dividend (bonus shares), share
          split, combination or exchange of shares, recapitalization, or any
          other like event by or of the Company, and as often as the same shall
          occur, then the number, class and kind of the Shares subject to the
          ISOP or subject to any Awards therefore granted, and the Purchase
          Prices, shall be appropriately and equitably adjusted so as to
          maintain the proportionate number of Shares without changing the
          aggregate Purchase Price, provided, however, that no adjustment shall
          be made by reason of the distribution of subscription rights (rights
          offering) on outstanding shares. Upon occurrence of any of the
          foregoing, the class and aggregate number of Shares issuable pursuant
          to the ISOP (as set forth in paragraph 6 hereof), in respect of which
          Awards have not yet been exercised or vested, shall be appropriately
          adjusted, all as will be determined by the Board whose determination
          shall be final.

                                       11
<PAGE>

     9.6  Anything herein to the contrary notwithstanding, in case of a
          Transaction, all or substantially all of the shares of the Company are
          to be exchanged for the securities of another Company, then each
          Grantee shall be obliged to sell or exchange, as the case may be, any
          Shares such Grantee purchased under the ISOP, in accordance with the
          instructions issued by the Board, whose determination shall be final.

10.  TERM AND EXERCISE OF OPTIONS

     10.1 Options shall be exercised by the Grantee by giving written notice to
          the Company, in such form and method as may be determined by the
          Company and the Trustee when applicable, in accordance with the
          requirements of Section 102, which exercise shall be effective upon
          receipt of such notice by the Company at its principal office. The
          notice shall specify the number of Shares with respect to which the
          Option is being exercised.

     10.2 Each Option granted under the ISOP, shall be exercisable following the
          Vesting Dates and subject to the provisions of the ISOP for the number
          of Shares as shall be provided in the Award Agreement. However no
          Options shall be exercisable after the Expiration Date.

     10.3 Options to the extent not previously exercised, shall terminate
          forthwith upon the earlier of: (i) the date set forth in the Option
          Agreement; and (ii) the expiration of any extended period in any of
          the events set forth in section 10.6 below.

     10.4 The Options may be exercised by the Grantee in whole at any time or in
          part from time to time, to the extent that the Options become vested
          and exercisable, prior to the Expiration Date, and provided that,
          subject to the provisions of section 10.6 below, the Grantee is an
          employee or providing services to the Company or any of its
          Affiliates, at all times during the period beginning with the granting
          of the Option and ending upon the date of exercise.

     10.5 Subject to the provisions of section 10.6 below, in the event of
          termination of Grantee's employment or services, with the Company or
          any of its Affiliates, all Options granted to him will immediately be
          expired. A notice of termination of employment or service shall be
          deemed to constitute termination of employment or service.

     10.6 Notwithstanding anything to the contrary hereinabove, an Option may be
          exercised after the date of termination of Grantee's employment or
          service with the Company or any Affiliate of the Company during an
          additional period of time beyond the date of such termination, but
          only with respect to the number of Options already vested at the time
          of such termination according to the Vesting Dates of the Options, if:
          (i) termination is without Cause, in which event any Options still in
          force and unexpired may be exercised within a period of ninety (90)
          days after the date of such termination, (ii) termination is the
          result of death or disability of the Grantee, in which event any
          Options still in force and unexpired may be exercised within a period
          of twelve (12) months after the date of such termination, or (iii)
          prior to the date of such termination, the Board shall authorize an
          extension of the terms of all or part of the Options beyond the date
          of such termination for a period not to exceed the period during which
          the Options by their terms would otherwise have been exercisable.

                                       12
<PAGE>

     10.7 To avoid doubt, the Grantees shall not have any of the rights or
          privileges of shareholders of the Company in respect of any Shares
          purchasable upon the exercise of any Option, nor shall they be deemed
          to be a class of shareholders or creditors of the Company for purpose
          of the operation of sections 350 and 351 of the Companies Law or any
          successor to such section, until registration of the Grantee as holder
          of such Shares in the Company's register of shareholders upon exercise
          of the Option in accordance with the provisions of the ISOP.

     10.8 Any form of Award Agreement authorized by the ISOP may contain such
          other provisions as the Committee may, from time to time, deem
          advisable.

     10.9 With respect to Unapproved 102 Option, if the Grantee ceases to be
          employed by the Company or any Affiliate, the Grantee shall extend to
          the Company and/or its Affiliate a security or guarantee for the
          payment of tax due at the time of sale of Shares, all in accordance
          with the provisions of Section 102 and the rules, regulation or orders
          promulgated thereunder.

11.  TERMS OF APPROVED 102 AWARDS OF RESTRCITED SHARES

     11.1 Eligibility. Not withstanding anything to the contrary in this ISOP
          and subject to Sections 4-6 above, Approved 102 Awards of Restricted
          Shares may be issued to Employees either alone or in addition to other
          Awards granted under the ISOP. The Board or Committee shall determine
          the eligible Employees to whom, and the time or times at which, grants
          of Restricted Shares will be made, the number of shares to be awarded
          as Approved 102 Awards, the purchase price (if any) to be paid by the
          Employee (subject to Section 11.2), the time or times at which such
          Approved 102 Awards may be subject to forfeiture (if any), the vesting
          schedule (if any) and rights to acceleration thereof, and all other
          terms and conditions of such Approved 102 Awards. The Board or
          Committee may condition the grant or vesting of Restricted Shares upon
          the attainment of specified performance targets or such other factors
          as the Board or Committee may determine, in its sole discretion.
          Unless otherwise determined by the Board or Committee the Employee
          shall not be permitted to sell or transfer shares of Restricted Shares
          awarded as Approved 102 Awards under this ISOP during a period set by
          the Board or Committee (if any) (the "RESTRICTION PERIOD") commencing
          with the date of such Approved 102 Award, as set forth in the
          applicable Award agreement.

     11.2 Terms. An Employee selected to receive Approved 102 Awards of
          Restricted Shares shall not have any rights with respect to such
          Approved 102 Award, unless and until such Employee has delivered a
          fully executed copy of the Award Agreement evidencing the Approved 102
          Award to the Company and/or the Trustee and has otherwise complied
          with the applicable terms and conditions of such Approved 102 Award
          and the provision of this ISOP. The Purchase Price of Restricted
          Shares shall be determined by the Board or Committee, but shall not be
          less than as permitted under applicable law. Approved 102 Awards of
          Restricted Shares must be accepted within a period of 60 days (or such
          shorter period as the Board or Committee may specify at grant) after
          the grant date, by executing an Award Agreement and by paying whatever
          price (if any) the Board or Committee has designated thereunder all
          subject to the provisions of Section 5-6 above.

                                       13
<PAGE>

     11.3 Legend. Each Employee receiving Approved 102 Awards of Restricted
          Shares shall be issued a share certificate in respect of such shares
          of Restricted Shares, unless the Company elects to use another system,
          such as book entries by the transfer agent, as evidencing ownership of
          Restricted Shares. Such certificate shall be registered in the name of
          the Trustee for the benefit of the Employee and shall bear an
          appropriate legend referring to the terms, conditions, and
          restrictions applicable to such Approved 102 Award, substantially in
          the following form (as well as other legend required by the Board or
          Committee pursuant to this ISOP):

          "The anticipation, alienation, attachment, sale, transfer, assignment,
          pledge, encumbrance or charge of the shares represented hereby are
          subject to the terms and conditions (including forfeiture) of the
          Healthcare Technologies Ltd. 2003 Israeli Share and Option Plan, as
          amended as of August 27, 2007 and an Award Agreement entered into
          between the registered owner and the Company dated [____________].
          Copies of such plan and Award agreement are on file at Healthcare
          Technologies Ltd."

     11.4 Rights as Shareholder. Except as provided in this Section and as
          otherwise determined by the Board or Committee and set forth in the
          Award Agreement, the Employee shall have, with respect to the Shares
          of Restricted Shares, all of the rights of a holder of Shares
          including, without limitation, the right to receive any dividends, the
          right to vote such Shares and, subject to and conditioned upon the
          full vesting of Shares of Restricted Shares, the right to tender or
          sell such Shares, all subject to the provision of Section 102 and the
          rules, regulations or orders promulgated thereunder. Notwithstanding
          the foregoing, the payment of dividends shall be deferred until, and
          conditioned upon, the expiration of the applicable Restriction Period,
          unless the Board or Committee, in its sole discretion, specifies
          otherwise at the time of the Approved 102 Award.

     11.5 Lapse of Restrictions. If and when the Restriction Period expires
          without a prior forfeiture of the Restricted Shares subject to such
          Restriction Period, all legends shall be removed from said
          certificates at that time except as otherwise required by applicable
          law.

12.  VESTING OF AWARDS

     The total number of Shares subject to an Award may, but need not, vest and
     therefore become extricable in periodic installments that may, but need
     not, be equal. The Award may be subject to such other terms and conditions
     on the time or times when it may be exercised (which may be based on
     performance or other criteria) as the Board may deem appropriate. The
     vesting provisions of individual Award may vary.

                                       14
<PAGE>

13.  PURCHASE FOR INVESTMENT

     The Company's obligation to issue or allocate Shares upon exercise of an
     Award granted under the ISOP is expressly conditioned upon: (a) the
     Company's completion of any registration or other qualifications of such
     Shares under all applicable laws, rules and regulations or (b)
     representations and undertakings by the Grantee (or his legal
     representative, heir or legatee, in the event of the Grantee's death) to
     assure that the sale of the Shares complies with any registration exemption
     requirements which the Company in its sole discretion shall deem necessary
     or advisable. Such required representations and undertakings may include
     representations and agreements that such Grantee (or his legal
     representative, heir, or legatee): (a) is purchasing such Shares for
     investment and not with any present intention of selling or otherwise
     disposing thereof; and (b) agrees to have placed upon the face and reverse
     of any certificates evidencing such Shares a legend setting forth (i) any
     representations and undertakings which such Grantee has given to the
     Company or a reference thereto and (ii) that, prior to effecting any sale
     or other disposition of any such Shares, the Grantee must furnish to the
     Company an opinion of counsel, satisfactory to the Company, that such sale
     or disposition will not violate the applicable requirements of any
     applicable laws.

14.  DIVIDENDS

     With respect to all Shares (but excluding, for avoidance of any doubt, any
     unexercised Options) allocated or issued upon the exercise of Options
     purchased by the Grantee and held by the Grantee or by the Trustee, as the
     case may be, the Grantee shall be entitled to receive dividends in
     accordance with the quantity of such Shares, and subject to any applicable
     taxation on distribution of dividends, and when applicable subject to the
     provisions of Section 102 and the rules, regulations or orders promulgated
     thereunder.

15.  ASSIGNABILITY AND SALE OF AWARDS

     No Award or any right with respect thereto, purchasable hereunder, whether
     fully paid or not, shall be assignable, transferable or given as collateral
     or any right with respect to it given to any third party whatsoever, except
     as specifically allowed under the ISOP, and during the lifetime of the
     Grantee each and all of such Grantee's rights to purchase Shares hereunder
     shall be exercisable only by the Grantee.

     Any such action made directly or indirectly, for an immediate validation or
     for a future one, shall be void.

     As long as the Shares are held by the Trustee on behalf of the Grantee, all
     rights of the Grantee over the Shares are personal, can not be transferred,
     assigned, pledged or mortgaged, other than by will or pursuant to the laws
     of descent and distribution.

                                       15
<PAGE>

16.  TERMS OF THE ISOP

     The ISOP shall terminate on August 28, 2008.

     The Company shall obtain the approval of the Company's shareholders for the
     adoption of this ISOP or for any amendment to this ISOP, if shareholders'
     approval is necessary or desirable to comply with any applicable law,
     including without limitation, the US securities law or the securities laws
     of other jurisdiction applicable to Awards granted to Grantees under this
     ISOP, or if shareholders' approval is required by any authority or by any
     governmental agencies or national securities exchanges, including without
     limitation, the US Securities and Exchange Commission.

17.  AMENDMENTS OR TERMINATION

     The Board may at any time, but when applicable, after consultation with the
     Trustee, amend, alter, suspend or terminate the ISOP. No amendment,
     alteration, suspension or termination of the ISOP shall impair the rights
     of any Grantee, unless mutually agreed otherwise between the Grantee and
     the Company, which agreement must be in writing and signed by the Grantee
     and the Company. Termination of the ISOP shall not affect the Committee's
     ability to exercise the powers granted to it hereunder with respect to
     Awards granted under the ISOP prior to the date of such termination.

18.  GOVERNMENT REGULATIONS

     The ISOP, and the granting, vesting and/or exercise of Awards hereunder,
     and the obligation of the Company to sell and deliver Shares under such
     Awards, shall be subject to all applicable laws, rules, and regulations,
     whether of the State of Israel or of the United States or any other State
     having jurisdiction over the Company and the Grantee, including the
     registration of the Shares under the United States Securities Act of 1933,
     and the Ordinance and to such approvals by any governmental agencies or
     national securities exchanges as may be required. Nothing herein shall be
     deemed to require the Company to register the Shares under the securities
     laws of any jurisdiction.

19.  CONTINUANCE OF EMPLOYMENT OR HIRED SERVICES

     Neither the ISOP nor the Award Agreement with the Grantee shall impose any
     obligation on the Company or an Affiliate thereof, to continue any Grantee
     in its employ or the hiring by the Company of the Grantee's services and
     nothing in the ISOP or in any Award granted pursuant thereto shall confer
     upon any Grantee any right to continue in the employ or service of the
     Company or an Affiliate thereof or restrict the right of the Company or an
     Affiliate thereof to terminate such employment or service hiring at any
     time.

20.  GOVERNING LAW & JURISDICTION

     The ISOP shall be governed by and construed and enforced in accordance with
     the laws of the State of Israel applicable to contracts made and to be
     performed therein, without giving effect to the principles of conflict of
     laws. The competent courts of Tel-Aviv, Israel shall have sole jurisdiction
     in any matters pertaining to the ISOP.

                                       16
<PAGE>

21.  TAX CONSEQUENCES

     Any tax consequences arising from the grant, vesting or exercise of any
     Award, from the payment for Shares covered thereby or from any other event
     or act (of the Company and/or its Affiliates, the Trustee or the Grantee),
     hereunder, shall be borne solely by the Grantee. The Company and/or its
     Affiliates and/or the Trustee shall withhold taxes according to the
     requirements under the applicable laws, rules, and regulations, including
     withholding taxes at source. Furthermore, the Grantee shall agree to
     indemnify the Company and/or its Affiliates and/or the Trustee and hold
     them harmless against and from any and all liability for any such tax or
     interest or penalty thereon, including without limitation, liabilities
     relating to the necessity to withhold, or to have withheld, any such tax
     from any payment made to the Grantee.

     The Committee and/or the Trustee shall not be required to release any Share
     certificate to a Grantee until all required payments have been fully made.

22.  NON-EXCLUSIVITY OF THE ISOP

     The adoption of the ISOP by the Board shall not be construed as amending,
     modifying or rescinding any previously approved incentive arrangements or
     as creating any limitations on the power of the Board to adopt such other
     incentive arrangements as it may deem desirable, including, without
     limitation, the granting of Awards otherwise than under the ISOP, and such
     arrangements may be either applicable generally or only in specific cases.
     For the avoidance of doubt, prior grant of Awards to Grantees of the
     Company under their employment agreements, and not in the framework of any
     previous share and option plan, shall not be deemed an approved incentive
     arrangement for the purpose of this Section.

23.  MULTIPLE AGREEMENTS

     The terms of each Award may differ from other Awards granted under the ISOP
     at the same time, or at any other time. The Board may also grant more than
     one Award to a given Grantee during the term of the ISOP, either in
     addition to, or in substitution for, one or more Awards previously granted
     to that Grantee.

                                       17Option Agreement, dated as of September 14, 2007

 Exhibit 10.1 
 OPTION AGREEMENT 
 THIS OPTION AGREEMENT (this “Agreement”) is made and entered into
as of September 14, 2007 by and among Meeting Street Investments LLC, a Delaware limited liability company (together with its successors and permitted assigns, “MS LLC”) and Radian Guaranty, Inc., a Pennsylvania corporation
(together with its successors and permitted assigns, “Radian”). 
 WHEREAS, the principals of MS LLC each owns an indirect
Interest in Sherman Financial Group LLC, a Delaware limited liability company (“Sherman Financial”) and may each desire to increase their direct or indirect equity interests in Sherman Financial; and 
 WHEREAS, as part of the 2007 Transactions and concomitantly with the sale by Radian of 300,000 Preferred Units and 1,672,547 Class A Common Units
(as such Preferred Units and Class A Common Units exist before giving effect to the Recapitalization) to Sherman Capital, L.L.C., a Delaware limited liability company and an affiliate of MS LLC (“Sherman Capital”), Radian is
willing to sell to MS LLC and MS LLC is willing to purchase from Radian, an option to purchase all of Radian’s remaining Interest in Sherman Financial. 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereto agree as follows:

 Section 1. Grant of Call Option. 
 (a) Radian hereby grants to MS LLC an irrevocable option (the “Call Option”), on the terms set forth in Section 2 below, to require Radian to sell to MS LLC on the Call Settlement Date a number
of Common Units in Sherman Financial corresponding to the Call Option Amount in consideration of the payment by MS LLC to Radian of the Call Settlement Price. 
 (b) The Call Option shall expire immediately following the exercise thereof or, if unexercised, shall expire as of the close of business on the date that is 365 days after the Effective Date or, if such date is not a
Business Day, as of the close of business of the following Business Day. 
 (c) Definitions. For purposes of this Agreement, the
following terms shall have the following meaning: 
 “Business Day” means any day other than (a) Saturday or Sunday or
(b) a day on which commercial banks in New York, New York, are authorized or required by applicable Law or executive order to close. 
 “Call Exercise Date” has the meaning set forth in Section 2. 
 “Call Exercise Period” means
the period beginning on the Effective Date and ending on the date that is 365 days after the Effective Date or, if such date is not a Business Day, the following Business Day. 

 “Call Option Amount” means, as of any date of determination during the Call Exercise
Period, the aggregate percentage of Radian’s ownership in Sherman Financial (or, if applicable, of any of Radian’s successors or permitted assigns). 
 “Call Settlement Date” has the meaning set forth in Section 2. 
 “Call
Settlement Price” means an amount equal to the Call Option Amount as of the Call Settlement Date multiplied by $1.5 billion and reduced by an amount equal to fifty (50) percent of all distributions made by Sherman Financial with
respect to the Call Option Amount from and including the Effective Date to and including the Call Settlement Date. 
 “Effective
Date” has the meaning set forth in Section 3. 
 “Governmental Entity” means any foreign, federal, state or
local government and any agency or instrumentality thereof, including, without limitation, any court or regulatory body. 
 “Law” means any statute, law, ordinance, regulation, rule, code, order, rule of common law or judgment enacted, promulgated, issued, enforced or entered by any Governmental Entity. 
 “Party” or “Parties” means the Persons party to this Agreement who appear on the signature page to this Agreement.

 “Radian” has the meaning set forth in the introductory paragraph to this Agreement. 
 “Recapitalization” has the meaning set forth in the Sherman Securities Purchase Agreement. 
 “Representatives” means, with respect to any Party, such Party’s agents, representatives (including its employees, attorneys and
consultants, financial or otherwise) and affiliates. 
 “Sherman Financial” has the meaning set forth in the first recital
to this Agreement. 
 “Sherman Financial LLC Agreement” means the Fifth Amended and Restated Limited Liability Company
Agreement of Sherman Financial, effective as of September 1, 2007. 
 All other capitalized terms used herein without definition shall
have the respective meanings ascribed to them in the Sherman Financial LLC Agreement. 
 As used in this Agreement, unless the context
otherwise requires, words in the singular include the plural and words in the plural include the singular. A reference to any Party to this Agreement or any other agreement or document shall include such Party’s successors and permitted
assigns. A reference to any agreement or order shall include any amendment of such agreement or order from time to time in accordance with the terms herewith and therewith. A reference to any legislation, to any provision of any 

  

 2 

 
legislation or to any regulation issued thereunder shall include any amendment to, and any modification or re-enactment thereof, any legislative provision or
regulation substituted therefor and all regulations issued thereunder or pursuant thereto. The headings contained in this Agreement are for convenience and reference only and do not form a part of this Agreement. Section references in this Agreement
refer to sections of this Agreement unless otherwise specified. 
 Section 2. Exercise of Call Option. 
 (i) MS LLC shall have the right, but not the obligation, to exercise its Call Option on any Business Day during the Call Exercise Period (such date of
exercise, the “Call Exercise Date”), by giving written notice to Radian indicating that it will purchase the Common Units in Sherman Financial corresponding to the Call Option Amount pursuant to its Call Option, on a date no sooner
than five (5) Business Days and no later than ten (10) Business Days after the Call Exercise Date (such purchase date, the “Call Settlement Date”). 
 (ii) Unless otherwise agreed by the Parties, MS LLC shall make payment on the Call Settlement Date of the Call Settlement Price in immediately available
funds to the account specified in writing by Radian to MS LLC. On the Call Settlement Date, Radian will deliver the Common Units in Sherman Financial corresponding to the Call Option Amount to MS LLC, free and clear of all Liens, other than such
Liens as may arise under the Sherman Financial LLC Agreement. 
 Section 3. Effectiveness. 
 This Agreement shall become effective on the date on which the transactions contemplated by the Sherman Securities Purchase Agreement are consummated
(such date, the “Effective Date”). 
 Section 4. Representations of Radian. As a material inducement to MS LLC
to enter into this Agreement and consummate the transactions contemplated hereby, Radian hereby represents and warrants to MS LLC as follows: 
 (i) Organization. Radian is a corporation validly existing and in good standing (or its equivalent) under the laws of the State of its incorporation. 
 (ii) Equity Interests and Related Matters. There are no statutory or contractual preemptive rights or rights of first refusal or Liens or other similar restrictions with respect to the grant of the Call Option
or the purchase and sale of Common Units in Sherman Financial pursuant to the Call Option (other than those contained in the Sherman Financial LLC Agreement). Except for the Sherman Financial LLC Agreement, there are no agreements or understandings
between Radian and any other persons with respect to the voting or transfer of Radian’s Interest in Sherman Financial or with respect to any other aspect of Sherman Financial’s governance. 
 (iii) Authorization. The execution, delivery and performance of this Agreement and all of the other agreements executed in connection with this
Agreement to which such Radian is a party and the grant of the Call Option hereunder and the sale of the Common Units in Sherman Financial hereunder by Radian have been duly authorized Radian. This Agreement, when executed and delivered by Radian in
accordance with the terms hereof, shall constitute a valid and binding obligation of Radian, enforceable against Radian in accordance with its terms. 
  

 3 

 (iv) Noncontravention. The execution and delivery by Radian of this Agreement, the grant of the
Call Option and the sale of the Common Units in Sherman Financial hereunder and the fulfillment of and compliance with the terms hereof do not and will not (i) conflict with or result in a material breach of the terms, conditions or provisions
of, (ii) constitute a material default under (whether with or without the passage of time, the giving of notice or both), (iii) result in the creation of any Lien upon Radian’s Interest, or (iv) require that Radian obtain or make
any authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any third party or any Governmental Entity pursuant to any Law or judgment enacted, promulgated, issued, enforced or entered by any
Governmental Entity to which such Radian is subject, the organizational documents of Radian or any material agreement, instrument, order, judgment or decree to which Radian is subject (other than the Sherman Financial LLC Agreement), except as has
not had and would not have a material adverse effect on Radian’s ability to consummate the transactions contemplated by this Agreement. 
 (v) No Brokers or Finders. Other than Samuel J. Weinhoff, neither Radian nor any of its directors, officers, employees, shareholders or agents have retained, employed or used any broker or finder in connection with the transactions
contemplated by this Agreement or in connection with the negotiation thereof. 
 Section 5. Miscellaneous. 
 (a) Actions Following Call Option Exercise. Upon payment of the Call Settlement Price, MS LLC and Radian shall take all such action as may be
necessary under the Sherman Financial LLC Agreement to reflect the transactions consummated pursuant to this Agreement on the books and records of Sherman Financial. At the reasonable request of any other Party hereto and without further
consideration, each Party hereto shall execute and deliver such additional documents and take such further action as may be necessary or appropriate under all applicable Laws to consummate and make effective, in the most expeditious manner
practicable, the exercise of the Call Option and the transfer of Radian’s Interest purchased by MS LLC pursuant to the exercise thereof. 
 (b) Disclosure, Announcements, Confidentiality. (i) Except as otherwise required by Law or the rules of the New York Stock Exchange, as such Law and rules are interpreted by counsel (who may be inside counsel) for a Party, no
Party shall, or shall permit any of its Affiliates to, issue or cause the publication of any press release or other public announcement with respect to, or otherwise make any public statement concerning, the transactions contemplated by this
Agreement without prior consultation of the other Party. 
 (ii) The Parties hereto agree to keep the transactions contemplated by this
Agreement and all other agreements and documents executed in connection with the 2007 Transactions (other than this Agreement itself and the terms hereof) (the “Confidential Information”) strictly confidential, and no Party shall,
without the prior written consent of the other Party, disclose the 

  

 4 

 
Confidential Information to any person (other than its Representatives), except to the extent a Party is advised by its counsel (who may be internal counsel)
that such disclosure is required by Law (in which case, the provisions of the following sentence shall apply). Notwithstanding anything in this Agreement to the contrary, (a) in the event that a Party hereto is advised by its counsel that
disclosure of any item constituting Confidential Information is required by Law, it is agreed that such Party or its Representative, as the case may be, (x) shall notify the other Party of such requirement as promptly as practicable,
(y) may, without liability hereunder, disclose such item in the manner it is advised is required by Law and (z) will exercise its best efforts to have confidential treatment accorded to any provision of such item that a Party hereto
reasonably requests to have accorded such treatment if such requesting Party takes primary responsibility for preparing and, to the extent permissible by Law, processing such request and (b) disclosure of any item of Confidential Information
shall be permitted hereunder if and to the extent expressly permitted by any provision of such item of Confidential Information. 
 (c)
Binding Effect. This Agreement shall inure to the benefit of and be binding upon the Parties hereto and their successors. This Agreement may not be assigned by any Party hereto without the prior written consent of the other Party hereto,
except that (i) MS LLC may assign any or all of its rights, interests and obligations hereunder to any member of the Sherman Capital Group, any member of Sherman Capital or any Affiliate of any member of Sherman Capital and (ii) Radian
shall assign any or all of its rights, interests and obligations hereunder to any member of the Radian Group, Radian Group, Inc. or any of the Affiliates of Radian Group, Inc. to the extent another member of the Radian Group, Radian Group Inc. or
any of its Affiliates would become the owner of any or all of Radian’s Interest during the Call Exercise Period, in the case of either clause (i) or clause (ii), without the prior consent of the other Party; provided, that any such
assignee agrees in writing to be bound by all of the terms, conditions and provisions contained herein. 
 (d) Governing Law. THIS
AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS THAT WOULD REQUIRE THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION. 
 (e) Resolutions of Disputes. 
 (i)
Generally. Unless prohibited by applicable Law, the Parties agree that any dispute, controversy or claim arising out of or relating to this Agreement or the performance by the Parties of its terms shall be settled by binding arbitration held
in the Borough of Manhattan, City of New York, State of New York in accordance with the Commercial Arbitration Rules of the American Arbitration Association then in effect, except as specifically otherwise provided in this Section 5(e).
Notwithstanding the foregoing, to the extent the arbitrator(s) does not possess the power to subpoena witnesses necessary to the resolution of a dispute, controversy or claim brought hereunder which a court of competent jurisdiction would possess,
such dispute, controversy or claim shall not be subject to the terms of this Section 5(e) and shall instead be subject to resolution in such court. If the Parties to the Sherman Financial LLC Agreement are engaged in or submit a matter to
arbitration with respect to or related to the same subject matter as a matter which is to be submitted to arbitration pursuant to this Agreement, such arbitrations shall be jointly conducted. 
  

 5 

 (ii) Arbitrators. If the matter in controversy (exclusive of attorney fees and expenses) shall
appear, as at the time of the demand for arbitration, to exceed $500,000, then the panel to be appointed shall consist of three neutral arbitrators; otherwise, one neutral arbitrator. No arbitrator shall be a current or former officer, manager,
director or employee of any Party or any member of Sherman Financial. 
 (iii) Procedures: No Appeal. The arbitrator(s) shall allow
such discovery as the arbitrator(s) determines appropriate under the circumstances and shall resolve the dispute as expeditiously as practicable, and if reasonably practicable, within 120 days after the selection of the arbitrator(s). The
arbitrator(s) shall give the Parties written notice of the decision, with the reasons therefor set out, and shall have 30 days thereafter to reconsider and modify such decision if any Party so requests within 10 days after the decision. Thereafter,
the decision of the arbitrator(s) shall be final, binding, and nonappealable with respect to all persons, including (without limitation) persons who have failed or refused to participate in the arbitration process, except to the extent such decision
shall be premised upon an erroneous application of or shall be contrary to applicable Law. In making any decision, the arbitrator(s) is instructed to preserve, as nearly as possible, to the extent compatible with applicable Law, the original
business and economic intent of the Parties embodied in this Agreement. 
 (iv) Authority. The arbitrator(s) shall have authority to
award relief under legal or equitable principles, including interim or preliminary relief, and to allocate responsibility for the costs of the arbitration and to award recovery of attorneys’ fees and expenses in such manner as is determined to
be appropriate by the arbitrator(s). 
 (v) Entry of Judgment. Judgment upon the award rendered by the arbitrator(s) may be entered
in any court having in personam and subject matter jurisdiction. Each Party hereby submits to the in personam jurisdiction of the federal and state courts in the Southern District of New York, and in the borough of Manhattan for the purpose of
confirming any such award and entering judgment thereon. 
 (vi) Confidentiality. Subject to Section 5(b) hereof, all
proceedings under this Section 5(e) and all evidence given or discovered pursuant hereto, shall be maintained in confidence by all Parties and by the arbitrators. 
 (vii) Continued Performance. The fact that the dispute resolution procedures specified in this Section 5(e) shall have been or may be invoked shall not excuse any Party from performing its obligations
under this Agreement and during the pendency of any such procedure all Parties shall continue to perform their respective obligations in good faith. 
 (viii) Tolling. All applicable statutes of limitation shall be tolled while the procedures specified in this Section 5(e) are pending. The Parties will take such action, if any, required to effectuate such
tolling. 
 (f) Waiver of Jury Trial. WITHOUT LIMITING SECTION 5(E), AND ONLY TO THE EXTENT THAT ANY PROVISION OF SECTION 5(E) IS HELD
BY A COURT OF COMPETENT JURISDICTION NOT TO BE ENFORCEABLE, 

  

 6 

 
EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES THE RIGHT TO A TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM THEREIN TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW. 
 (g)
Amendments. Neither this Agreement nor any provision hereof may be amended, modified or waived except by an instrument in writing duly signed by or on behalf of the Parties. 
 (h) Specific Performance. The Parties hereto agree that irreparable damage would occur in the event any provision of this Agreement was not
performed in accordance with the terms hereof and that the Parties hereto shall be entitled to specific performance of the terms hereof, in addition to any other remedy at Law or in equity. 
 (i) Notice. Notices, requests, permissions, waivers, and other communications hereunder shall be in writing and shall be deemed to have been duly
given when received if delivered by facsimile transmission: 
 If to Radian: 
 Radian Guaranty, Inc. 
 1601 Market Street 
 Philadelphia, PA 19103-2337 
 Attention:
General Counsel 
 Telephone No.: (215) 231-1647 
 Fax No.: (215) 405-9160 
 If to MS LLC: 
 Meeting Street Investments LLC 
 c/o Sherman Capital Markets LLC 
 200 Meeting Street 
 Charleston, South
Carolina 29401 
 Attention: General Counsel 
 Telephone No.: (843) 266-1717 
 Telecopy No.: (843) 722-1884 
 (j) Headings. The headings of this Agreement are for convenience of reference only and shall not define or limit the provisions hereof.

 (k) Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument. 
  

 7 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date first above
written. 
  

			
	RADIAN GUARANTY, INC.
		
	By:	 	 /s/ Mark A. Casale

	Name:	 	Mark A. Casale
	Title:	 	President
	
	MEETING STREET INVESTMENTS LLC
		
	By:	 	 /s/ Leslie G. Gutierrez

	Name:	 	Leslie G. Gutierrez
	Title:	 	Authorized Representative

 Signature Page to Option Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]